Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients

被引：35
|
作者：
Patil, Sandeep S. [1 ]
Gentschev, Ivaylo [1 ,2 ]
Nolte, Ingo [3 ]
Ogilvie, Gregory [4 ,5 ]
Szalay, Aladar A. [1 ,2 ,5 ,6 ,7 ]
机构：
[1] Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany
[2] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA
[3] Univ Vet Med, Small Anim Clin, D-30173 Hannover, Germany
[4] Calif Vet Specialists, Angel Care Canc Ctr, Carlsbad, CA 92008 USA
[5] Univ Calif San Diego, Dept Radiat Oncol, Moores Canc Ctr, La Jolla, CA 92093 USA
[6] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany
[7] Univ Wurzburg, Inst Mol Infect Biol, D-97078 Wurzburg, Germany
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2012年 / 10卷
关键词：
cancer; canine cancer therapy; oncolytic virus; oncolysis; target molecule; combination therapy; ENDOTHELIAL GROWTH-FACTOR; REPLICATION-COMPETENT ADENOVIRUS; THYMIDINE KINASE-ACTIVITY; MESENCHYMAL STEM-CELLS; VACCINIA VIRUS; ANTITUMOR-ACTIVITY; IMMUNOHISTOCHEMICAL EXPRESSION; INTRATUMORAL SPREAD; MALIGNANT-LYMPHOMA; SYSTEMIC DELIVERY;
D O I：
10.1186/1479-5876-10-3
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Oncolytic viruses refer to those that are able to eliminate malignancies by direct targeting and lysis of cancer cells, leaving non-cancerous tissues unharmed. Several oncolytic viruses including adenovirus strains, canine distemper virus and vaccinia virus strains have been used for canine cancer therapy in preclinical studies. However, in contrast to human studies, clinical trials with oncolytic viruses for canine cancer patients have not been reported. An 'ideal' virus has yet to be identified. This review is focused on the prospective use of oncolytic viruses in the treatment of canine tumors - a knowledge that will undoubtedly contribute to the development of oncolytic viral agents for canine cancer therapy in the future.
引用
收藏
页数：10
相关论文
共 50 条
  • [1] Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
    Sandeep S Patil
    Ivaylo Gentschev
    Ingo Nolte
    Gregory Ogilvie
    Aladar A Szalay
    Journal of Translational Medicine, 10
  • [2] Oncolytic virotherapy for pediatric malignancies: future prospects
    Waters, Alicia M.
    Friedman, Gregory K.
    Ring, Eric K.
    Beierle, Elizabeth A.
    ONCOLYTIC VIROTHERAPY, 2016, 5 : 73 - 80
  • [3] Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status
    Zhang, Yuhui
    Liu, Zhuoming
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (40) : 4251 - 4263
  • [4] Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
    Msaouel, Pavlos
    Opyrchal, Mateusz
    Dispenzieri, Angela
    Peng, Kah Whye
    Federspiel, Mark J.
    Russell, Stephen J.
    Galanis, Evanthia
    CURRENT CANCER DRUG TARGETS, 2018, 18 (02) : 177 - 187
  • [5] Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective
    Ebrahimi, Safieh
    Ghorbani, Elnaz
    Shafiee, Mojtaba
    Ryzhikov, Mikhail
    Hassanian, Seyed M.
    Azadmanesh, Kayhan
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 2801 - 2809
  • [6] Oncolytic adenoviruses in anticancer therapy: Current status and prospects
    Svyatchenko, V. A.
    Tarasova, M. V.
    Netesov, S. V.
    Chumakov, M.
    MOLECULAR BIOLOGY, 2012, 46 (04) : 496 - 507
  • [7] An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas
    Stergiopoulos, Georgios M.
    Concilio, Susanna C.
    Galanis, Evanthia
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (07) : 952 - 991
  • [8] Oncolytic adenoviruses in anticancer therapy: Current status and prospects
    V. A. Svyatchenko
    M. V. Tarasova
    S. V. Netesov
    P. M. Chumakov
    Molecular Biology, 2012, 46 : 496 - 507
  • [9] Evidence synthesis and guideline development in genomic medicine: current status and future prospects
    Schully, Sheri D.
    Lam, Tram Kim
    Dotson, W. David
    Chang, Christine Q.
    Aronson, Naomi
    Birkeland, Marian L.
    Brewster, Stephanie Jo
    Boccia, Stefania
    Buchanan, Adam H.
    Calonge, Ned
    Calzone, Kathleen
    Djulbegovic, Benjamin
    Goddard, Katrina A. B.
    Klein, Roger D.
    Klein, Teri E.
    Lau, Joseph
    Long, Rochelle
    Lyman, Gary H.
    Morgan, Rebecca L.
    Palmer, Christina G. S.
    Ling, Mary V. Re
    Rubinstein, Wendy S.
    Swen, Jesse J.
    Terry, Sharon F.
    Williams, Marc S.
    Khoury, Muin J.
    GENETICS IN MEDICINE, 2015, 17 (01) : 63 - 67
  • [10] Anti-cancer Virotherapy in Russia: Lessons from the Past, Current Challenges and Prospects for the Future
    Kolyasnikova, Nadezhda M.
    Pestov, Nikolay B.
    Sanchez-Pimentel, Jeanne P.
    Barlev, Nikolay A.
    Ishmukhametov, Aidar A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023, 24 (02) : 266 - 278
12345